Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 31 | 2021 | 625 | 3.380 |
Why?
|
| Arthroplasty, Replacement, Hip | 25 | 2016 | 820 | 1.840 |
Why?
|
| Knee Joint | 12 | 2016 | 740 | 1.190 |
Why?
|
| Knee Prosthesis | 13 | 2021 | 222 | 1.160 |
Why?
|
| Reoperation | 29 | 2021 | 888 | 0.940 |
Why?
|
| Minimally Invasive Surgical Procedures | 7 | 2007 | 186 | 0.840 |
Why?
|
| Prosthesis Failure | 18 | 2021 | 533 | 0.690 |
Why?
|
| Tendons | 3 | 2006 | 222 | 0.630 |
Why?
|
| Osteoarthritis, Knee | 5 | 2017 | 361 | 0.590 |
Why?
|
| Patella | 6 | 2006 | 72 | 0.590 |
Why?
|
| Prosthesis Design | 17 | 2021 | 492 | 0.580 |
Why?
|
| Femur | 9 | 2010 | 381 | 0.570 |
Why?
|
| Humans | 62 | 2021 | 26260 | 0.550 |
Why?
|
| Postoperative Complications | 12 | 2021 | 825 | 0.500 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2006 | 72 | 0.480 |
Why?
|
| Range of Motion, Articular | 11 | 2016 | 692 | 0.470 |
Why?
|
| Acetabulum | 9 | 2009 | 231 | 0.470 |
Why?
|
| Tibia | 5 | 2019 | 244 | 0.440 |
Why?
|
| Treatment Outcome | 20 | 2016 | 3285 | 0.440 |
Why?
|
| Hemiarthroplasty | 1 | 2014 | 35 | 0.430 |
Why?
|
| Pain, Postoperative | 3 | 2006 | 312 | 0.420 |
Why?
|
| Orthopedic Procedures | 4 | 2016 | 300 | 0.400 |
Why?
|
| Joint Diseases | 3 | 2016 | 112 | 0.360 |
Why?
|
| Hip Prosthesis | 9 | 2016 | 551 | 0.360 |
Why?
|
| Middle Aged | 28 | 2021 | 8541 | 0.360 |
Why?
|
| Aged | 27 | 2021 | 8595 | 0.360 |
Why?
|
| Sound Spectrography | 1 | 2010 | 21 | 0.350 |
Why?
|
| Hip Fractures | 1 | 2010 | 26 | 0.350 |
Why?
|
| Blood Loss, Surgical | 2 | 2007 | 46 | 0.330 |
Why?
|
| Recovery of Function | 8 | 2016 | 285 | 0.320 |
Why?
|
| Radiography | 13 | 2016 | 594 | 0.320 |
Why?
|
| Follow-Up Studies | 17 | 2021 | 1722 | 0.310 |
Why?
|
| Male | 30 | 2021 | 14168 | 0.310 |
Why?
|
| Perioperative Care | 2 | 2006 | 43 | 0.310 |
Why?
|
| Female | 30 | 2021 | 14520 | 0.310 |
Why?
|
| Cementation | 6 | 2021 | 33 | 0.280 |
Why?
|
| Hemostasis, Surgical | 1 | 2007 | 12 | 0.280 |
Why?
|
| Electrocoagulation | 1 | 2007 | 12 | 0.280 |
Why?
|
| Clinical Competence | 2 | 2007 | 227 | 0.280 |
Why?
|
| Polyethylenes | 1 | 2006 | 39 | 0.260 |
Why?
|
| Critical Pathways | 1 | 2006 | 17 | 0.260 |
Why?
|
| Femoral Fractures | 1 | 2006 | 33 | 0.260 |
Why?
|
| Tendon Injuries | 2 | 2005 | 208 | 0.250 |
Why?
|
| Bone Transplantation | 2 | 2006 | 201 | 0.250 |
Why?
|
| Osteolysis | 4 | 2010 | 144 | 0.250 |
Why?
|
| Decision Support Techniques | 1 | 2005 | 47 | 0.230 |
Why?
|
| Lactones | 1 | 2003 | 9 | 0.220 |
Why?
|
| Time Factors | 9 | 2011 | 1347 | 0.220 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2003 | 27 | 0.220 |
Why?
|
| Isoenzymes | 1 | 2003 | 50 | 0.220 |
Why?
|
| Arthroplasty | 1 | 2004 | 146 | 0.210 |
Why?
|
| Hip Joint | 5 | 2016 | 543 | 0.210 |
Why?
|
| Adult | 18 | 2019 | 7516 | 0.200 |
Why?
|
| Arthroscopy | 2 | 2016 | 1085 | 0.190 |
Why?
|
| Prospective Studies | 6 | 2009 | 1665 | 0.190 |
Why?
|
| Ossification, Heterotopic | 2 | 2016 | 35 | 0.190 |
Why?
|
| Osteoarthritis, Hip | 2 | 2016 | 106 | 0.170 |
Why?
|
| Transplantation, Homologous | 3 | 2005 | 260 | 0.160 |
Why?
|
| Retrospective Studies | 10 | 2019 | 3283 | 0.160 |
Why?
|
| Biomechanical Phenomena | 4 | 2017 | 629 | 0.160 |
Why?
|
| Patient Selection | 2 | 2014 | 184 | 0.150 |
Why?
|
| Knee | 1 | 2017 | 43 | 0.140 |
Why?
|
| Pain Measurement | 4 | 2016 | 418 | 0.140 |
Why?
|
| Radiotherapy | 1 | 2016 | 31 | 0.130 |
Why?
|
| Aged, 80 and over | 11 | 2010 | 4594 | 0.130 |
Why?
|
| Medial Collateral Ligament, Knee | 1 | 2016 | 7 | 0.130 |
Why?
|
| Leg Length Inequality | 1 | 2016 | 9 | 0.130 |
Why?
|
| Braces | 1 | 2016 | 22 | 0.130 |
Why?
|
| Joint Instability | 3 | 2016 | 388 | 0.130 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 58 | 0.120 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2006 | 23 | 0.120 |
Why?
|
| Analgesia, Patient-Controlled | 2 | 2006 | 22 | 0.120 |
Why?
|
| Analgesia, Epidural | 2 | 2006 | 54 | 0.120 |
Why?
|
| Hip Dislocation | 1 | 2016 | 70 | 0.120 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2016 | 47 | 0.120 |
Why?
|
| Knee Injuries | 1 | 2016 | 202 | 0.110 |
Why?
|
| Posterior Cruciate Ligament | 2 | 2011 | 23 | 0.110 |
Why?
|
| Bone Cements | 4 | 2009 | 89 | 0.110 |
Why?
|
| Gait | 1 | 2017 | 396 | 0.110 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 72 | 0.110 |
Why?
|
| Risk Assessment | 4 | 2016 | 592 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2019 | 160 | 0.100 |
Why?
|
| Orthopedics | 2 | 2005 | 112 | 0.100 |
Why?
|
| Device Removal | 3 | 2009 | 89 | 0.100 |
Why?
|
| Osteotomy | 2 | 2003 | 166 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2014 | 201 | 0.090 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2010 | 1 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2016 | 1801 | 0.090 |
Why?
|
| Vibration | 1 | 2010 | 30 | 0.090 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2011 | 138 | 0.090 |
Why?
|
| Double-Blind Method | 2 | 2016 | 411 | 0.080 |
Why?
|
| Health Status Indicators | 2 | 2010 | 41 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2011 | 853 | 0.070 |
Why?
|
| Probability | 2 | 2004 | 86 | 0.070 |
Why?
|
| Marketing of Health Services | 1 | 2007 | 4 | 0.070 |
Why?
|
| Sodium Chloride | 1 | 2007 | 34 | 0.070 |
Why?
|
| Equipment Design | 1 | 2007 | 134 | 0.070 |
Why?
|
| Postoperative Period | 2 | 2019 | 326 | 0.070 |
Why?
|
| Bone Diseases | 1 | 2006 | 24 | 0.070 |
Why?
|
| Surface Properties | 1 | 2006 | 140 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2006 | 34 | 0.060 |
Why?
|
| Clinical Protocols | 1 | 2006 | 55 | 0.060 |
Why?
|
| Supine Position | 1 | 2006 | 20 | 0.060 |
Why?
|
| Demography | 1 | 2006 | 67 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2006 | 199 | 0.060 |
Why?
|
| Medical Laboratory Science | 1 | 2005 | 6 | 0.060 |
Why?
|
| Nerve Block | 1 | 2006 | 67 | 0.060 |
Why?
|
| Diffusion of Innovation | 1 | 2005 | 29 | 0.060 |
Why?
|
| Metals | 1 | 2006 | 150 | 0.060 |
Why?
|
| Decision Trees | 1 | 2005 | 13 | 0.060 |
Why?
|
| Markov Chains | 1 | 2005 | 30 | 0.060 |
Why?
|
| Early Ambulation | 1 | 2004 | 17 | 0.060 |
Why?
|
| Rupture | 1 | 2004 | 111 | 0.060 |
Why?
|
| Physical Therapy Modalities | 1 | 2004 | 72 | 0.060 |
Why?
|
| Weight-Bearing | 1 | 2004 | 158 | 0.060 |
Why?
|
| Arthroplasty, Replacement | 1 | 2006 | 153 | 0.060 |
Why?
|
| Dyssomnias | 1 | 2003 | 6 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 24 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 28 | 0.060 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2003 | 16 | 0.060 |
Why?
|
| Sulfones | 1 | 2003 | 20 | 0.060 |
Why?
|
| Disease Progression | 3 | 2016 | 676 | 0.050 |
Why?
|
| Osseointegration | 1 | 2003 | 67 | 0.050 |
Why?
|
| Inhalation | 1 | 2003 | 3 | 0.050 |
Why?
|
| Tibial Fractures | 1 | 2003 | 7 | 0.050 |
Why?
|
| Sex Factors | 1 | 2004 | 456 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2003 | 159 | 0.050 |
Why?
|
| Age Factors | 1 | 2004 | 744 | 0.050 |
Why?
|
| Musculoskeletal Diseases | 1 | 2003 | 42 | 0.050 |
Why?
|
| Length of Stay | 1 | 2003 | 290 | 0.050 |
Why?
|
| Preoperative Care | 2 | 2016 | 120 | 0.050 |
Why?
|
| Radiotherapy Dosage | 2 | 2016 | 116 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2003 | 211 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 314 | 0.040 |
Why?
|
| Quality of Life | 1 | 2005 | 606 | 0.040 |
Why?
|
| Risk | 1 | 2019 | 197 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2019 | 247 | 0.040 |
Why?
|
| Polyethylene | 1 | 2019 | 132 | 0.040 |
Why?
|
| Equipment Failure Analysis | 2 | 2010 | 106 | 0.040 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2010 | 40 | 0.040 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2016 | 16 | 0.030 |
Why?
|
| Physical Examination | 1 | 2016 | 110 | 0.030 |
Why?
|
| Risk Adjustment | 1 | 2016 | 10 | 0.030 |
Why?
|
| Prosthesis Fitting | 1 | 2016 | 21 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2016 | 36 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2016 | 127 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 493 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2005 | 242 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 386 | 0.030 |
Why?
|
| Health Care Costs | 2 | 2004 | 72 | 0.030 |
Why?
|
| Osteoarthritis | 1 | 2016 | 316 | 0.020 |
Why?
|
| Risk Factors | 2 | 2010 | 2221 | 0.020 |
Why?
|
| Polymethacrylic Acids | 1 | 2010 | 4 | 0.020 |
Why?
|
| Illinois | 1 | 2010 | 223 | 0.020 |
Why?
|
| United States | 2 | 2006 | 2043 | 0.020 |
Why?
|
| Patellofemoral Joint | 1 | 2010 | 66 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 249 | 0.020 |
Why?
|
| Blood Sedimentation | 1 | 2007 | 44 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2007 | 63 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2007 | 92 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2007 | 95 | 0.020 |
Why?
|
| Prosthesis-Related Infections | 1 | 2009 | 186 | 0.020 |
Why?
|
| Pelvic Bones | 1 | 2006 | 18 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 473 | 0.020 |
Why?
|
| Orthopedic Equipment | 1 | 2005 | 3 | 0.020 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2005 | 5 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2005 | 22 | 0.020 |
Why?
|
| Porosity | 1 | 2004 | 60 | 0.010 |
Why?
|
| Contraindications | 1 | 2004 | 30 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 29 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2004 | 122 | 0.010 |
Why?
|
| Incidence | 1 | 2006 | 709 | 0.010 |
Why?
|
| Bone Wires | 1 | 2003 | 10 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 122 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2003 | 131 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2003 | 21 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 294 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 2003 | 45 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2003 | 397 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 1069 | 0.010 |
Why?
|